Generic Name and Formulations:
Chlorpheniramine maleate 4mg; tabs.
Merck & Co., Inc.
Indications for CHLOR-TRIMETON:
Allergic and vasomotor rhinitis, conjunctivitis, pruritus.
4mg every 4–6hrs; max 24mg/24hrs.
<6yrs: not recommended. 6–11yrs: 2mg every 4–6hrs; max 12mg/24hrs.
Asthma and lower respiratory disorders. Glaucoma. GI or GU obstruction. Pregnancy, nursing mothers: not recommended.
Potentiates CNS depression with alcohol, other CNS depressants.
Anticholinergic effects, drowsiness, dizziness, paradoxical excitement.
Neurology Advisor Articles
- Rasagiline Plus Riluzole is Safe, May Improve Survival in ALS
- Treatment of New-Onset Epilepsy: AAN, AES Update Practice Guidelines
- Gender Differences in the Epidemiology of Migraine
- Changes in Glucose Regulation in Parkinson Disease
- Apomorphine Infusions Improves Off Time Associated With Parkinson Disease
- Some Statins May Be Associated With Cognition, Memory Deficits
- Neuropathic Pain Treatments
- Cannabis for Multiple Sclerosis: Prescriber's Perspective
- New Monoclonal Antibody BAN2401 Reduces Amyloid Plaques, Improves Cognition in Alzheimer's
- Nonpharmacologic Interventions for Alzheimer's Have Greater Impact on Outcomes Than Currently Available Medications
- Locally Asymptomatic Ischemic Stroke May Present as Migraine Aura
- Associations Identified Between Stroke Severity, Recovery of Visuospatial Neglect
- Action Tremor May Have Central Origin in Motor Neuron Disease
- Characteristics Affecting Health-Related Quality of Life in RRMS, Progressive MS
- Neurodevelopmental Anomalies, Birth Defects Linked to Zika ID'd